Reviewing Biotricity (OTCMKTS:BTCY) & TransAlta (OTCMKTS:TAC)

Biotricity (OTCMKTS:BTCY) and TransAlta (NYSE:TAC) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.

Earnings and Valuation

This table compares Biotricity and TransAlta’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Biotricity N/A N/A N/A N/A N/A
TransAlta $1.74 billion 1.00 -$152.76 million ($0.53) -11.53

Biotricity has higher earnings, but lower revenue than TransAlta.

Volatility and Risk

Biotricity has a beta of 4.52, meaning that its stock price is 352% more volatile than the S&P 500. Comparatively, TransAlta has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500.

Insider and Institutional Ownership

0.0% of Biotricity shares are owned by institutional investors. Comparatively, 50.0% of TransAlta shares are owned by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.


This table compares Biotricity and TransAlta’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Biotricity N/A N/A N/A
TransAlta -14.67% -8.73% -3.03%

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Biotricity and TransAlta, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biotricity 0 0 0 0 N/A
TransAlta 0 2 2 0 2.50


TransAlta pays an annual dividend of $0.12 per share and has a dividend yield of 2.0%. Biotricity does not pay a dividend. TransAlta pays out -22.6% of its earnings in the form of a dividend.


TransAlta beats Biotricity on 5 of the 9 factors compared between the two stocks.

About Biotricity

Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, focuses on providing biometric data monitoring solutions in the United States. The company focuses to deliver remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It is developing Bioflux mobile cardiac telemetry solution that provides recurring reimbursements to doctors, hospitals, and independent diagnostic testing facilities; revenue model that fits within the established insurance billing practices; built-in cellular connectivity; and motion tracking to detect exercise, activity, and disorientation. The company is also developing Biolife, a health and lifestyle solution for individuals. It has a collaboration agreement with the University of Calgary to determine the predictive value of electrocardiogram readings in preventative healthcare applications. Biotricity, Inc. is based in Redwood City, California.

About TransAlta

TransAlta Corporation operates as non-regulated electricity generation and energy marketing company in Canada, the United States, and Western Australia. It operates through eight segments: Canadian Coal, U.S. Coal, Canadian Gas, Australian Gas, Wind and Solar, Hydro, Energy Marketing, and Corporate. The company generates and markets electricity through various generation fuels, such as coal, natural gas, water, solar, and wind. It also engages in wholesale trading of electricity and other energy-related commodities and derivatives. The company operates facilities with approximately 9,331 megawatts of aggregate generating capacity. TransAlta Corporation was founded in 1909 and is headquartered in Calgary, Canada.

Receive News & Ratings for Biotricity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotricity and related companies with's FREE daily email newsletter.